Pharma & Biotech - Page 2

STEPLogic Trace is positioning itself as a key solution for pharmaceutical companies navigating the complex requirements of DSCSA-compliant supply chains. The platform helps pharmaceutical supply chains produce certified EPCIS outputs, enabling companies

Alnylam Pharmaceuticals (ALNY) shares collapsed nearly 28% on Thursday, closing at $206.88 after the company reported disappointing Amvuttra sales and slashed its full-year outlook. The RNA interference therapy crossed the $1 billion

Pharmaceutical companies are being urged to assess whether their serialization systems can keep pace with expanding business demands and regulatory requirements. Serialization has become a cornerstone of modern pharmaceutical supply chain management,

Pfizer (PFE) has announced that its drug Litfulo met primary goals in two large late-stage studies for nonsegmental vitiligo, the most common form of the skin-pigmentation disorder. Both studies showed significantly more

The US Food and Drug Administration has moved into full enforcement of the Drug Supply Chain Security Act after an 18-month stabilisation grace period concluded. The enforcement shift marks a significant turning

Ember LifeSciences has entered into a capital and business alliance with Alfresa Corporation to strengthen pharmaceutical cold chain logistics across Japan. Alfresa Corporation is a subsidiary of Alfresa Holdings Corporation, which holds

Pharmaceutical manufacturers are accelerating investment in direct-to-patient models as policy shifts and rising consumer expectations reshape the industry landscape. Chip Parkinson, CEO of Gifthealth, says the momentum behind these integrated models has

Incyte Corporation has raised its full-year 2026 Opzelura net sales guidance to between $1.05 billion and $1.1 billion following a landmark settlement with the Centers for Medicare & Medicaid Services. The agreement

Biogen has dramatically reversed its 2026 revenue guidance, shifting from an anticipated mid-single-digit percentage decrease to an expected mid-single-digit percentage increase. The pharmaceutical company reported second-quarter 2026 total revenue of $2.7 billion,

Colonis Pharma Limited has been sanctioned by the Prescription Medicines Code of Practice Authority over a promotional letter for its Melatonin 1mg/ml Oral Solution product. The PMCPA ruled the letter breached multiple